Daily ideas

Hilton, Marriott and Choice say AI assistants can now book their hotels directly. Choice's AI-sourced visits rose over tenfold but are about 1% of direct visits.

Prudential Financial earned $4.08 per share of after-tax adjusted operating income in Q2 2026; Q3 tests whether the Japan sales suspension stays within its $525-575 million cost range.

BWXT and Lightbridge say commercial HALEU supply now limits advanced nuclear fuel expansion, as BWXT stretches its TRISO line and Centrus capacity waits for 2029.

PSEG's Q2 2026 operating EPS rose to $0.86 from $0.77 as nuclear capacity revenue climbed; Q3 earnings test whether $329 PJM prices outrun rising utility costs.

KKR's Q2 2026 fee related earnings rose 37% to $1.21 billion on record management fees; Q3 results test whether fee growth holds once catch-up fees fade.

BD grew fiscal Q3 2026 revenue 4.4% FX-neutral to $4.983 billion; Q4 results test whether GLP-1 devices and margins can offset the Alaris pump roll-off.

Wheaton posted record Q2 2026 revenue of $929 million but carries $1.9 billion of net debt after Antamina; Q3 tests whether that silver stream lifts output and cuts debt.

SMFG grew Q1 net interest income 26.4% to ¥791.9 billion as SMBC's yen spread hit 1.31%; first-half results test whether deposit costs caught up after the BoJ's 1% call rate.

Rockwell Automation grew Q3 sales 10% organically to $2.313 billion at a 22.3% margin; Q4 tests whether Logix holds double-digit growth as memory-chip costs bite.

Atlassian grew fiscal 2026 revenue 26% to $6.57 billion with a $10.4 million GAAP operating profit; Q1 tests whether Cloud keeps ~28.5% growth as Data Center declines.

Cardinal Health grew fiscal 2026 revenue 14% to $254.2 billion and non-GAAP EPS 37% to $11.26; Q1 tests whether Pharma profit keeps outgrowing GLP-1-driven sales.

Yum! Brands grew Q2 2026 revenue 12% to $2,169 million with Core Operating Profit up 8% ex-Pizza Hut; Q3 tests whether Taco Bell U.S. margin holds 19%-21% after the lettuce recall.

Natera grew Q2 2026 revenue 37.7% to $752.8 million on 283,000 clinical MRD tests; Q3 earnings test whether Signatera volume keeps climbing as true-ups fade.

Astera Labs grew Q2 2026 revenue 104% to $392.4M at a 73.7% non-GAAP gross margin; Q3 earnings test whether Scorpio X lifts sales to the $540M-$560M guide.

Estée Lauder grew fiscal 2026 sales 5% to $15.05 billion and lifted adjusted operating margin to about 11.2%; Q1 tests whether Asia travel retail demand or restocking drives growth.

Waters grew Q2 2026 revenue 113% to $1.645 billion after buying BD's biosciences unit; Q3 tests whether legacy LC-MS holds 8%-10% growth and BDS reaches $895 million.

eBay says active sellers in Australia using its Magical Listing AI tool create over one-third more listings per attempter, but it has not quantified GMV or revenue impact.

Murata will spend ¥1 trillion over five years to more than double MLCC sales, with ¥650 billion going to equipment first; barium titanate and coater suppliers sit upstream.